British System Highlights Cost-Effectiveness Concerns as Part of U.S. Overhaul Effort
While Congress recently approved funds to study the cost-effectiveness of certain treatments, some are concerned that such research could lead to rationing of health care or that treatments deemed less effective will not be adequately covered, the AP/Washington Post reports. Those concerned often cite Great Britain's National Institute for Health and Clinical Excellence, which determines which medical treatments will be covered based on cost-effectiveness. One of the criteria used by NICE to determine a treatment's cost-effectiveness is how much each additional year of life will cost the government, which the agency has capped at about $47,000 per year of life in most cases (Cheng, AP/Washington Post, 5/26).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
